Olink

Olink®
Part of Thermo Fisher Scientific

Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity

Leukemia & Lymphoma, 2018

Lendvai N., Tsakos I., Devlin S., Schaffer W., Hassoun H., Lesokhin A., Landau H., Korde N., Mailankody S., Smith E., Chung D., Koehne G., Shah G., Alexander A., Patel M., Ballagi A., Grundberg I., Giralt S., Landgren O.

Disease areaApplication areaSample typeProducts
CVD
Patient Stratification
Plasma
Olink Target 96

Olink Target 96

Abstract

Letter to Editor article – format without an abstract.

Read publication ↗